These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 2159272

  • 1. Expression of intermediate filaments in neuroendocrine tumors.
    Kimura N, Nakazato Y, Nagura H, Sasano N.
    Arch Pathol Lab Med; 1990 May; 114(5):506-10. PubMed ID: 2159272
    [Abstract] [Full Text] [Related]

  • 2. Synaptophysin and neurofilament proteins as markers for neuroendocrine tumors.
    Miettinen M.
    Arch Pathol Lab Med; 1987 Sep; 111(9):813-8. PubMed ID: 2820344
    [Abstract] [Full Text] [Related]

  • 3. Immunocytochemical demonstration of intermediate filament cytoskeleton proteins in human endocrine tissues and (neuro-) endocrine tumours.
    Hoefler H, Denk H, Lackinger E, Helleis G, Polak JM, Heitz PU.
    Virchows Arch A Pathol Anat Histopathol; 1986 Sep; 409(5):609-26. PubMed ID: 3092460
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Production of immunoreactive corticotropin-releasing hormone in various neuroendocrine tumors.
    Tsuchihashi T, Yamaguchi K, Abe K, Yanaihara N, Saito S.
    Jpn J Clin Oncol; 1992 Aug; 22(4):232-7. PubMed ID: 1359172
    [Abstract] [Full Text] [Related]

  • 6. Varying expression of cytokeratin and neurofilaments in neuroendocrine tumors of human gastrointestinal tract.
    Miettinen M, Lehto VP, Dahl D, Virtanen I.
    Lab Invest; 1985 Apr; 52(4):429-36. PubMed ID: 2580121
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Synaptophysin expression in neuroendocrine neoplasms as determined by immunocytochemistry.
    Gould VE, Wiedenmann B, Lee I, Schwechheimer K, Dockhorn-Dworniczak B, Radosevich JA, Moll R, Franke WW.
    Am J Pathol; 1987 Feb; 126(2):243-57. PubMed ID: 3103452
    [Abstract] [Full Text] [Related]

  • 10. Expression of intermediate filament proteins in thyroid gland and thyroid tumors.
    Miettinen M, Franssila K, Lehto VP, Paasivuo R, Virtanen I.
    Lab Invest; 1984 Mar; 50(3):262-70. PubMed ID: 6199582
    [Abstract] [Full Text] [Related]

  • 11. Detection of epithelial- and neural type of intermediate filament proteins in human lung tumors.
    Ramaekers F, Broers J, Rot MK, Oostendorp T, Wagenaar S, Vooijs P.
    Acta Histochem Suppl; 1987 Mar; 34():45-56. PubMed ID: 3033739
    [Abstract] [Full Text] [Related]

  • 12. Coexpression of intermediate filaments in squamous cell carcinomas of upper aerodigestive tract before and after radiation and chemotherapy.
    Fischer HP, Wallner F, Maier H, Weber K, Osborn M, Altmannsberger M.
    Lab Invest; 1989 Oct; 61(4):433-9. PubMed ID: 2477642
    [Abstract] [Full Text] [Related]

  • 13. Familial risk for neuroendocrine tumors.
    Anderson RJ, Lynch HT.
    Curr Opin Oncol; 1993 Jan; 5(1):75-84. PubMed ID: 8094015
    [Abstract] [Full Text] [Related]

  • 14. Primitive neuroectodermal tumors of the central nervous system. Patterns of expression of neuroendocrine markers, and all classes of intermediate filament proteins.
    Gould VE, Jansson DS, Molenaar WM, Rorke LB, Trojanowski JQ, Lee VM, Packer RJ, Franke WW.
    Lab Invest; 1990 Apr; 62(4):498-509. PubMed ID: 2159086
    [Abstract] [Full Text] [Related]

  • 15. Immunoreactivity of neurofilament proteins in neuroendocrine neoplasms.
    Shah IA, Schlageter MO, Netto D.
    Mod Pathol; 1991 Mar; 4(2):215-9. PubMed ID: 1646456
    [Abstract] [Full Text] [Related]

  • 16. [Sipple's syndrome: type II endocrine polyneoplasia (author's transl)].
    Bricaire H, Mahoudeau J.
    Ann Med Interne (Paris); 1979 Dec; 130(12):611-5. PubMed ID: 44158
    [Abstract] [Full Text] [Related]

  • 17. Thyroid transcription factor-1 is expressed in extrapulmonary small cell carcinomas but not in other extrapulmonary neuroendocrine tumors.
    Agoff SN, Lamps LW, Philip AT, Amin MB, Schmidt RA, True LD, Folpe AL.
    Mod Pathol; 2000 Mar; 13(3):238-42. PubMed ID: 10757334
    [Abstract] [Full Text] [Related]

  • 18. [Pathology of endocrine polyneoplasms (polyadenomatoses) (author's transl)].
    Louvel A, Abelanet R.
    Ann Med Interne (Paris); 1979 Dec; 130(12):583-9. PubMed ID: 44154
    [Abstract] [Full Text] [Related]

  • 19. Galanin immunoreactivity in neuroendocrine tumors.
    Sano T, Vrontakis ME, Kovacs K, Asa SL, Friesen HG.
    Arch Pathol Lab Med; 1991 Sep; 115(9):926-9. PubMed ID: 1718239
    [Abstract] [Full Text] [Related]

  • 20. Absence of TP53 alterations in pheochromocytomas and medullary thyroid carcinomas.
    Herfarth KK, Wick MR, Marshall HN, Gartner E, Lum S, Moley JF.
    Genes Chromosomes Cancer; 1997 Sep; 20(1):24-9. PubMed ID: 9290950
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.